As we return from an energizing week at SCOPE 2026 in Orlando, one thing is clear: the industry conversation has evolved. The focus has shifted from experimentation to execution — from “Should we modernize?” to “How…
Clinical trials are becoming increasingly global. Studies now run across countries, involve participants from different cultures, and collect data from multiple healthcare systems. In principle, this should support broader representation and stronger evidence. But in practice,…
Team TrialX at SCOPE 2026: Sharib Khan (Co-founder & CEO), Wes Martz (Senior Director of Client Services), Beth Dickson (VP, Business Development), and Brandon Ramos (Sales Development Representative) SCOPE 2026 once again brought together leaders across…
The 17th Annual SCOPE Summit once again brought together leaders across clinical operations, digital health, patient engagement, and data innovation to shape the future of clinical research. This year, the tone was clear: the industry is…
🦃 This holiday season, we’re especially grateful for partnerships that bring hope to patients and families. We are honored to power the AI-based clinical trial finder for ALK Positive, a patient-driven organization dedicated to improving the…
Throwback to October 13th! We were honored to power the Clinical Trial Finder for the groundbreaking Reflections initiative, a program transforming how communities engage with clinical research. Designed to enhance diversity in clinical trials and raise…
Making clinical trials more diverse isn’t just the right thing to do — it’s essential for developing treatments that work for everyone. Yet, despite FDA guidance, many trials still fail to reflect the real-world diversity of…
